Investor pages
Firm pages
Latest filing period, portfolio scale, and public materials.
73 firms
Himalaya Capital
Li Lu
Himalaya Capital founder, long-term value and China business quality
View profile
$3.2B
Portfolio value
14
holdings
2026-03-31
Latest 13F
H&H International Investment
Duan Yongping
H&H International Investment, Duan Yongping's owner-operator view of long-term investing
View profile
$20.0B
Portfolio value
12
holdings
2026-03-31
Latest 13F
Pabrai Investment Funds / Dalal Street
Mohnish Pabrai
Pabrai Investment Funds / Dalal Street, Dhandho value and concentrated public teaching
View profile
$422.9M
Portfolio value
3
holdings
2026-03-31
Latest 13F
Pershing Square Capital Management
Bill Ackman
Pershing Square founder, activist investing through letters and presentations
View profile
$13.7B
Portfolio value
10
holdings
2026-03-31
Latest 13F
Third Point
Dan Loeb
Third Point, Dan Loeb's event-driven, activist and letter-rich strategy
View profile
$2.1B
Portfolio value
20
holdings
2026-03-31
Latest 13F
Coatue Management
Philippe Laffont
Coatue Management, Philippe Laffont's technology, AI and crossover growth platform
View profile
$29.1B
Portfolio value
20
holdings
2026-03-31
Latest 13F
All firms
Browse by 13F recency, portfolio scale, and public materials
73 firms
13F / public materials / profile pages
| Firm | Strategy | Positions | Portfolio value | Content |
|---|---|---|---|---|
|
|
Quality value / insurance float | 20 holdings | $263.1B Portfolio | 14 |
Himalaya Capital
Li Lu
|
Long-term value / China compounders | 14 holdings | $3.2B Portfolio | 4 |
H&H International Investment
Duan Yongping
|
Concentrated quality / Apple-Berkshire-PDD | 12 holdings | $20.0B Portfolio | 13 |
Pabrai Investment Funds / Dalal Street
Mohnish Pabrai
|
Concentrated value | 3 holdings | $422.9M Portfolio | 13 |
Pershing Square Capital Management
Bill Ackman
|
Activist / concentrated quality | 10 holdings | $13.7B Portfolio | 13 |
|
|
Opportunistic / macro-aware equities | 20 holdings | $5.9B Portfolio | 2 |
|
|
High-quality global compounders | 20 holdings | $12.8B Portfolio | 13 |
|
|
Value / distressed / special situations | 20 holdings | $5.1M Portfolio | 2 |
Third Point
Dan Loeb
|
Event-driven / activist | 20 holdings | $2.1B Portfolio | 4 |
Coatue Management
Philippe Laffont
|
Technology / growth / crossover | 20 holdings | $29.1B Portfolio | 2 |
Tiger Global Management
Chase Coleman
|
Technology growth / crossover | 20 holdings | $22.8B Portfolio | 2 |
HHLR Advisors / Hillhouse
Lei Zhang
|
Asia growth / healthcare / technology | 20 holdings | $1.7B Portfolio | 2 |
Greenwoods / Jinglin
George Jiang
|
China value / long-term compounders | 20 holdings | $3.9B Portfolio | 2 |
Lone Pine Capital
Stephen Mandel
|
Quality growth / consumer internet | 20 holdings | $12.5B Portfolio | 2 |
Viking Global Investors
Andreas Halvorsen
|
Long/short quality growth | 20 holdings | $35.7B Portfolio | 2 |
Duquesne Family Office
Stanley Druckenmiller
|
Macro / concentrated equities | 20 holdings | $3.4M Portfolio | 3 |
|
|
Macro / systematic asset allocation | 20 holdings | $22.4B Portfolio | 3 |
|
|
Macro / opportunistic equities | 20 holdings | $9.1B Portfolio | 2 |
|
|
Activist / control-oriented value | 12 holdings | $8.6B Portfolio | 2 |
TCI Fund Management
Chris Hohn
|
Concentrated quality / activist | 10 holdings | $45.2B Portfolio | 2 |
Akre Capital Management
Chuck Akre
|
Quality compounders | 17 holdings | $6.1B Portfolio | 2 |
Polen Capital Management
-
|
Quality growth | 20 holdings | $14.5B Portfolio | 2 |
GQG Partners
Rajiv Jain
|
Global quality / emerging markets | 20 holdings | $63.1B Portfolio | 2 |
|
|
Concentrated value / legacy Munger watchlist | 4 holdings | $240.7M Portfolio | 3 |
Oaktree Capital Management
Howard Marks
|
Credit cycles / distressed value | 20 holdings | $6.3B Portfolio | 13 |
Gotham Asset Management
Joel Greenblatt
|
Quality value / special situations | 20 holdings | $32.7B Portfolio | 2 |
Markel Group
Tom Gayner
|
Insurance float / quality compounders | 20 holdings | $11.9B Portfolio | 5 |
Fairfax Financial
Prem Watsa
|
Insurance / value / macro-aware | 20 holdings | $1.9B Portfolio | 5 |
Giverny Capital
Francois Rochon
|
Quality compounders | 20 holdings | $2.7B Portfolio | 5 |
Miller Value Partners
Bill Miller
|
Contrarian value / growth value | 20 holdings | $383.2M Portfolio | 2 |
Oakmark / Harris Associates
Bill Nygren
|
Value / intrinsic value discipline | 20 holdings | $75.0B Portfolio | 2 |
Southeastern Asset Management
Mason Hawkins
|
Concentrated value / appraisal discipline | 20 holdings | $2.0B Portfolio | 2 |
Dorsey Asset Management
Pat Dorsey
|
Moat investing / quality compounders | 11 holdings | $1.3B Portfolio | 2 |
Davis Advisors
Chris Davis
|
Owner earnings / durable franchises | 20 holdings | $21.8B Portfolio | 2 |
First Eagle legacy
Jean-Marie Eveillard
|
Global value / capital preservation | 20 holdings | $75.6B Portfolio | 1 |
|
|
Concentrated value | 10 holdings | $4.6B Portfolio | 2 |
Lindsell Train
Nick Train
|
UK quality compounders / brands | 13 holdings | $3.1B Portfolio | 1 |
|
|
Long-duration growth / innovation | 20 holdings | $97.9B Portfolio | 2 |
Baron Capital
Ron Baron
|
Growth / founder-led companies | 20 holdings | $33.1B Portfolio | 2 |
|
|
Quality value / concentrated franchises | 20 holdings | $6.0B Portfolio | 5 |
|
|
Concentrated activist value | 18 holdings | $5.7B Portfolio | 0 |
Valley Forge Capital Management
Dev Kantesaria
|
Concentrated quality compounders | 7 holdings | $3.4B Portfolio | 0 |
Vulcan Value Partners
C.T. Fitzpatrick
|
Value / business-quality discipline | 20 holdings | $3.8B Portfolio | 0 |
Weitz Investment Management
Wallace Weitz
|
Value / owner earnings | 20 holdings | $1.4B Portfolio | 0 |
|
|
Classic value / global value | 20 holdings | $1.3B Portfolio | 0 |
Gardner Russo & Quinn
Thomas Russo
|
Global consumer franchises / family-controlled businesses | 18 holdings | $8.5B Portfolio | 0 |
|
|
Concentrated quality compounders | 12 holdings | $962.9M Portfolio | 0 |
Semper Augustus Investments Group
Christopher Bloomstran
|
Value / Berkshire-style capital allocation | 20 holdings | $837.3M Portfolio | 0 |
|
|
Low-turnover value / long game | 20 holdings | $4.6B Portfolio | 0 |
Brave Warrior Advisors
Glenn Greenberg
|
Concentrated value / quality franchises | 18 holdings | $4.0B Portfolio | 0 |
|
|
Quality value / shareholder yield | 20 holdings | $7.5B Portfolio | 0 |
|
|
Concentrated large-cap growth | 20 holdings | $15.5B Portfolio | 0 |
|
|
Long-term quality value | 20 holdings | $29.8B Portfolio | 0 |
Whale Rock Capital Management
Alex Sacerdote
|
Technology growth / active long-short | 20 holdings | $7.7B Portfolio | 0 |
|
|
Technology growth / long-duration compounding | 20 holdings | $59.5B Portfolio | 0 |
Altimeter Capital Management
Brad Gerstner
|
Technology / travel / platform growth | 12 holdings | $5.7B Portfolio | 0 |
|
|
Crossover growth / internet platforms | 17 holdings | $3.0B Portfolio | 0 |
Durable Capital Partners
Henry Ellenbogen
|
Long-duration growth / crossover | 20 holdings | $9.7B Portfolio | 0 |
|
|
Concentrated quality growth | 16 holdings | $4.1B Portfolio | 0 |
Soroban Capital Partners
Eric Mandelblatt
|
Concentrated industrials / infrastructure / quality growth | 20 holdings | $51.8B Portfolio | 0 |
Glenview Capital Management
Larry Robbins
|
Healthcare / event-driven active equity | 20 holdings | $4.0B Portfolio | 0 |
Eminence Capital
Ricky Sandler
|
Fundamental long-short / active equities | 20 holdings | $4.4B Portfolio | 0 |
Corvex Management
Keith Meister
|
Activist / event-driven value | 19 holdings | $2.5B Portfolio | 0 |
Starboard Value
Jeff Smith
|
Activist value / operational improvement | 19 holdings | $4.6B Portfolio | 0 |
Sachem Head Capital Management
Scott Ferguson
|
Activist / concentrated value | 17 holdings | $4.2B Portfolio | 0 |
|
|
Event-driven / activist value | 20 holdings | $5.5B Portfolio | 0 |
|
|
Biotech / healthcare specialist | 20 holdings | $17.4B Portfolio | 0 |
Sands Capital Management
Frank Sands
|
Growth / innovation platforms | 20 holdings | $25.5B Portfolio | 0 |
Ariel Investments
John Rogers
|
Patient value / small and mid-cap quality | 20 holdings | $8.9B Portfolio | 0 |
|
|
Quality growth / durable franchises | 20 holdings | $999.7M Portfolio | 0 |
|
|
Value / high active share | 20 holdings | $6.6B Portfolio | 0 |
Wedgewood Partners
David Rolfe
|
Focused growth / business quality | 20 holdings | $484.3M Portfolio | 0 |
|
|
Classic value / Graham tradition | 20 holdings | $564.1M Portfolio | 0 |